questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines et peptides de signalisation intracellulaire
Protein-Serine-Threonine Kinases
Mitogen-Activated Protein Kinases
JNK Mitogen-Activated Protein Kinases
JNK Mitogen-Activated Protein Kinases : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Kinases
Signalisation cellulaire
Biomarqueurs
Phosphorylation
Tests génétiques
Mutations
Imagerie par résonance magnétique
Effets cellulaires
Échantillons sanguins
Marqueurs d'activation
Symptômes
5
Cancer
Maladies neurodégénératives
Troubles cognitifs
Troubles de l'humeur
Prévention
5
Mode de vie sain
Alimentation équilibrée
Stress oxydatif
Gestion du stress
Antioxydants
Stress oxydatif
Exercice physique
Modulation
Habitudes alimentaires
Nutriments
Traitements
5
Inhibiteurs
Développement thérapeutique
Anti-inflammatoires
Modulation
Thérapie génique
Dysfonctionnements
Plantes médicinales
Activation
Traitements anticancéreux
Cellules tumorales
Complications
5
Maladies inflammatoires
Cancer
Complications cardiovasculaires
Maladies cardiovasculaires
Vieillissement cellulaire
Activation prolongée
Troubles neurodégénératifs
Activation
Troubles métaboliques
Diabète
Facteurs de risque
5
Stress
Inflammation chronique
Alimentation
Graisses saturées
Tabagisme
Facteurs de risque
Toxines environnementales
Activation
Mode de vie sédentaire
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "JNK Mitogen-Activated Protein Kinases : Questions médicales les plus fréquentes",
"headline": "JNK Mitogen-Activated Protein Kinases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les JNK Mitogen-Activated Protein Kinases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-10",
"dateModified": "2025-05-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "JNK Mitogen-Activated Protein Kinases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Mitogen-Activated Protein Kinases",
"url": "https://questionsmedicales.fr/mesh/D020928",
"about": {
"@type": "MedicalCondition",
"name": "Mitogen-Activated Protein Kinases",
"code": {
"@type": "MedicalCode",
"code": "D020928",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.567"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Mitogen-Activated Protein Kinase 8",
"alternateName": "Mitogen-Activated Protein Kinase 8",
"url": "https://questionsmedicales.fr/mesh/D048055",
"about": {
"@type": "MedicalCondition",
"name": "Mitogen-Activated Protein Kinase 8",
"code": {
"@type": "MedicalCode",
"code": "D048055",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.567.374.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mitogen-Activated Protein Kinase 9",
"alternateName": "Mitogen-Activated Protein Kinase 9",
"url": "https://questionsmedicales.fr/mesh/D048056",
"about": {
"@type": "MedicalCondition",
"name": "Mitogen-Activated Protein Kinase 9",
"code": {
"@type": "MedicalCode",
"code": "D048056",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.567.374.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mitogen-Activated Protein Kinase 10",
"alternateName": "Mitogen-Activated Protein Kinase 10",
"url": "https://questionsmedicales.fr/mesh/D048057",
"about": {
"@type": "MedicalCondition",
"name": "Mitogen-Activated Protein Kinase 10",
"code": {
"@type": "MedicalCode",
"code": "D048057",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.567.374.800"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "JNK Mitogen-Activated Protein Kinases",
"alternateName": "JNK Mitogen-Activated Protein Kinases",
"code": {
"@type": "MedicalCode",
"code": "D048031",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mohammad Shafiq",
"url": "https://questionsmedicales.fr/author/Mohammad%20Shafiq",
"affiliation": {
"@type": "Organization",
"name": "From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India."
}
},
{
"@type": "Person",
"name": "Kumaravelu Jagavelu",
"url": "https://questionsmedicales.fr/author/Kumaravelu%20Jagavelu",
"affiliation": {
"@type": "Organization",
"name": "From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India."
}
},
{
"@type": "Person",
"name": "Neeraj Kumar Verma",
"url": "https://questionsmedicales.fr/author/Neeraj%20Kumar%20Verma",
"affiliation": {
"@type": "Organization",
"name": "Division of Molecular and Structural Biology (N.K.V., J.K.G.), CSIR-Central Drug Research Institute, Lucknow, India."
}
},
{
"@type": "Person",
"name": "Jimut Kanti Ghosh",
"url": "https://questionsmedicales.fr/author/Jimut%20Kanti%20Ghosh",
"affiliation": {
"@type": "Organization",
"name": "Division of Molecular and Structural Biology (N.K.V., J.K.G.), CSIR-Central Drug Research Institute, Lucknow, India."
}
},
{
"@type": "Person",
"name": "Matthias Gaestel",
"url": "https://questionsmedicales.fr/author/Matthias%20Gaestel",
"affiliation": {
"@type": "Organization",
"name": "Institute for Zellbiochemie, Medizinische Hochschule Hannover (MHH), Hanover, Germany (M.G.)."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Effect of placenta location detected by ultrasound on the severity of placenta accreta spectrum in patients with placenta previa and placenta accreta spectrum.",
"datePublished": "2023-06-01",
"url": "https://questionsmedicales.fr/article/37264325",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12884-023-05736-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Placenta Accreta Spectrum.",
"datePublished": "2023-06-07",
"url": "https://questionsmedicales.fr/article/37290094",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/AOG.0000000000005229"
}
},
{
"@type": "ScholarlyArticle",
"name": "Physiology and Pathophysiology of the Placenta.",
"datePublished": "2023-05-22",
"url": "https://questionsmedicales.fr/article/37240411",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24109066"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identification of Preeclamptic Placenta in Whole Slide Images Using Artificial Intelligence Placenta Analysis.",
"datePublished": "2024-10-14",
"url": "https://questionsmedicales.fr/article/39403751",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3346/jkms.2024.39.e271"
}
},
{
"@type": "ScholarlyArticle",
"name": "Correlation of placental thickness and placenta percreta in patients with placenta previa: findings from MRI.",
"datePublished": "2022-09-17",
"url": "https://questionsmedicales.fr/article/36114883",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00261-022-03676-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protein-Serine-Threonine Kinases",
"item": "https://questionsmedicales.fr/mesh/D017346"
},
{
"@type": "ListItem",
"position": 6,
"name": "Mitogen-Activated Protein Kinases",
"item": "https://questionsmedicales.fr/mesh/D020928"
},
{
"@type": "ListItem",
"position": 7,
"name": "JNK Mitogen-Activated Protein Kinases",
"item": "https://questionsmedicales.fr/mesh/D048031"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : JNK Mitogen-Activated Protein Kinases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur JNK Mitogen-Activated Protein Kinases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur JNK Mitogen-Activated Protein Kinases",
"description": "Comment diagnostiquer une activation des JNK ?\nQuels biomarqueurs indiquent l'activation des JNK ?\nLes tests génétiques sont-ils utiles pour les JNK ?\nQuels examens d'imagerie sont utilisés pour les JNK ?\nPeut-on mesurer l'activité des JNK dans le sang ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Placenta#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur JNK Mitogen-Activated Protein Kinases",
"description": "Quels symptômes sont liés à l'activation des JNK ?\nLes JNK sont-ils impliqués dans des maladies ?\nComment les JNK affectent-ils la douleur ?\nLes JNK influencent-ils le métabolisme ?\nY a-t-il des symptômes neurologiques associés aux JNK ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Placenta#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur JNK Mitogen-Activated Protein Kinases",
"description": "Comment prévenir l'activation des JNK ?\nLe stress influence-t-il les JNK ?\nLes antioxydants aident-ils à prévenir l'activation des JNK ?\nL'exercice physique prévient-il l'activation des JNK ?\nLes habitudes alimentaires influencent-elles les JNK ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Placenta#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur JNK Mitogen-Activated Protein Kinases",
"description": "Quels traitements ciblent les JNK ?\nLes anti-inflammatoires affectent-ils les JNK ?\nLa thérapie génique peut-elle cibler les JNK ?\nLes traitements naturels influencent-ils les JNK ?\nLes traitements anticancéreux ciblent-ils les JNK ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Placenta#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur JNK Mitogen-Activated Protein Kinases",
"description": "Quelles complications sont liées à l'activation des JNK ?\nLes JNK sont-ils liés à des complications cardiovasculaires ?\nLes JNK influencent-ils le vieillissement cellulaire ?\nY a-t-il des complications neurologiques liées aux JNK ?\nLes JNK sont-ils impliqués dans des complications métaboliques ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Placenta#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur JNK Mitogen-Activated Protein Kinases",
"description": "Quels facteurs de risque influencent les JNK ?\nL'alimentation affecte-t-elle les JNK ?\nLe tabagisme influence-t-il les JNK ?\nL'exposition à des toxines affecte-t-elle les JNK ?\nLe manque d'exercice est-il un facteur de risque pour les JNK ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Placenta#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une activation des JNK ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de signalisation cellulaire et des analyses protéomiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels biomarqueurs indiquent l'activation des JNK ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de protéines phosphorylées c-Jun peuvent indiquer une activation."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les JNK ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests peuvent identifier des mutations affectant la voie JNK."
}
},
{
"@type": "Question",
"name": "Quels examens d'imagerie sont utilisés pour les JNK ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie par résonance magnétique peut aider à visualiser des effets cellulaires."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer l'activité des JNK dans le sang ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échantillons sanguins peuvent être analysés pour des marqueurs d'activation."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à l'activation des JNK ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'activation peut entraîner inflammation, apoptose et dysfonction cellulaire."
}
},
{
"@type": "Question",
"name": "Les JNK sont-ils impliqués dans des maladies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont associés à des maladies comme le cancer et les maladies neurodégénératives."
}
},
{
"@type": "Question",
"name": "Comment les JNK affectent-ils la douleur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils modulent la signalisation de la douleur, contribuant à des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Les JNK influencent-ils le métabolisme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils jouent un rôle dans la régulation du métabolisme énergétique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés aux JNK ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles cognitifs et des troubles de l'humeur peuvent être observés."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'activation des JNK ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut aider."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il les JNK ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut activer les JNK, donc la gestion du stress est cruciale."
}
},
{
"@type": "Question",
"name": "Les antioxydants aident-ils à prévenir l'activation des JNK ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antioxydants peuvent réduire le stress oxydatif et l'activation des JNK."
}
},
{
"@type": "Question",
"name": "L'exercice physique prévient-il l'activation des JNK ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut moduler positivement l'activité des JNK."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles les JNK ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en nutriments peut réduire l'activation des JNK."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les JNK ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs spécifiques des JNK sont en développement pour diverses maladies."
}
},
{
"@type": "Question",
"name": "Les anti-inflammatoires affectent-ils les JNK ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains anti-inflammatoires peuvent moduler l'activité des JNK."
}
},
{
"@type": "Question",
"name": "La thérapie génique peut-elle cibler les JNK ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est explorée pour corriger des dysfonctionnements des JNK."
}
},
{
"@type": "Question",
"name": "Les traitements naturels influencent-ils les JNK ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines plantes médicinales peuvent avoir un effet sur l'activation des JNK."
}
},
{
"@type": "Question",
"name": "Les traitements anticancéreux ciblent-ils les JNK ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements anticancéreux visent à inhiber les voies JNK dans les cellules tumorales."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à l'activation des JNK ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'activation excessive des JNK peut entraîner des maladies inflammatoires et cancéreuses."
}
},
{
"@type": "Question",
"name": "Les JNK sont-ils liés à des complications cardiovasculaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'activation des JNK est associée à des maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les JNK influencent-ils le vieillissement cellulaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activation prolongée des JNK peut accélérer le vieillissement cellulaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications neurologiques liées aux JNK ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'activation des JNK est impliquée dans des troubles neurodégénératifs."
}
},
{
"@type": "Question",
"name": "Les JNK sont-ils impliqués dans des complications métaboliques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont liés à des troubles métaboliques comme le diabète."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque influencent les JNK ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress, l'inflammation chronique et l'obésité sont des facteurs de risque connus."
}
},
{
"@type": "Question",
"name": "L'alimentation affecte-t-elle les JNK ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses saturées peut augmenter l'activation des JNK."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il les JNK ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque qui peut activer les JNK."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines affecte-t-elle les JNK ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines environnementales peut activer les JNK."
}
},
{
"@type": "Question",
"name": "Le manque d'exercice est-il un facteur de risque pour les JNK ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut augmenter le risque d'activation des JNK."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 05/05/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India.
Academy of Scientific and Innovative Research, Ghaziabad, India (M.S., K.J., K.H.).
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India.
Academy of Scientific and Innovative Research, Ghaziabad, India (M.S., K.J., K.H.).
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Division of Molecular and Structural Biology (N.K.V., J.K.G.), CSIR-Central Drug Research Institute, Lucknow, India.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Division of Molecular and Structural Biology (N.K.V., J.K.G.), CSIR-Central Drug Research Institute, Lucknow, India.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Institute for Zellbiochemie, Medizinische Hochschule Hannover (MHH), Hanover, Germany (M.G.).
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India.
Academy of Scientific and Innovative Research, Ghaziabad, India (M.S., K.J., K.H.).
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
College of Life Sciences and National Key Laboratory of Crop Genetics and Germplasm Enhancement, Nanjing Agricultural University, Nanjing 210095, China.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Radiology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, Hubei, China.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Laboratório Especial de Dor e Sinalização, Instituto Butantan, São Paulo, Brazil.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Laboratório Especial de Dor e Sinalização, Instituto Butantan, São Paulo, Brazil.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Laboratório Especial de Dor e Sinalização, Instituto Butantan, São Paulo, Brazil.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
Department of Life Science (BK21 program), Chung-Ang University, Seoul, South Korea.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
Department of Life Science (BK21 program), Chung-Ang University, Seoul, South Korea.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
Department of Life Science (BK21 program), Chung-Ang University, Seoul, South Korea.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
Department of Life Science (BK21 program), Chung-Ang University, Seoul, South Korea.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
College of Horticulture, Northwest A&F University, Yangling 712100, China. tayebmuhammad@nwsuaf.edu.cn.
State Key Laboratory of Crop Stress Biology in Arid Regions, Northwest A&F University, Yangling 712100, China. tayebmuhammad@nwsuaf.edu.cn.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
College of Horticulture, Northwest A&F University, Yangling 712100, China. 15591858981@163.com.
State Key Laboratory of Crop Stress Biology in Arid Regions, Northwest A&F University, Yangling 712100, China. 15591858981@163.com.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
College of Horticulture, Northwest A&F University, Yangling 712100, China. 15891785931@163.com.
State Key Laboratory of Crop Stress Biology in Arid Regions, Northwest A&F University, Yangling 712100, China. 15891785931@163.com.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
College of Horticulture, Northwest A&F University, Yangling 712100, China. liyushunaf@163.com.
State Key Laboratory of Crop Stress Biology in Arid Regions, Northwest A&F University, Yangling 712100, China. liyushunaf@163.com.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
College of Horticulture, Northwest A&F University, Yangling 712100, China. feizhang@nwsuaf.edu.cn.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
To evaluate the effect of placental location on the severity of placenta accreta spectrum (PAS)....
We analyzed 390 patients with placenta previa combined with placenta accreta spectrum who underwent cesarean section between January 1, 2014 and December 30, 2020 in the electronic case database of th...
The history of cesarean delivery rates in the anterior group (91.67%) and the non-central group (85.71%) were statistically different from the posterior group (63.74%)(P < 0.001). Univariate logistic ...
Compared with posterior placenta, anterior and non-central placenta are independent risk factors for invasive PAS in patients with placenta previa, during which we should be more cautious in treatment...
Placenta accreta spectrum (PAS) is one of the most dangerous conditions in pregnancy and is increasing in frequency. The risk of life-threatening bleeding is present throughout pregnancy but is partic...
We are pleased to present this Special Issue of the...
Preeclampsia (PE) is a hypertensive pregnancy disorder linked to placental dysfunction, often involving pathological lesions like acute atherosis, decidual vasculopathy, accelerated villous maturation...
A total of 168 placental whole-slide images (WSIs) of patients from Seoul National University Hospital (comprising 84 PE cases and 84 normal controls) were used for model development and internal vali...
Using ensemble modeling, we developed a model to identify PE placentas. The model showed good performance (area under the precision-recall curve [AUPRC], 0.771; 95% confidence interval [CI], 0.752-0.7...
The proposed computational pathology model demonstrated a strong ability to identify preeclamptic placentas. Computational pathology has the potential to improve the identification of PE placentas....
This study aimed to identify if placental thickness measured from MRI images correlated with placenta percreta in patients with placenta previa....
Placental thickness was retrospectively measured in 161 patients from July 2018 to August 2020. The measurements were performed at the thickest part of the placenta in the lower uterine segment on the...
Placental thickness in patients with placenta percreta was significantly higher than in patients with placenta increta, placenta accreta, and normal placentas (p < 0.05). Multivariate analysis reveale...
Patients with placenta percreta had the highest placental thickness. Placental thickness was correlated with placenta percreta....
The objective of this study was to assess the performance of ultrasound and magnetic resonance imaging (MRI) features in helping to classify the type of placenta accreta spectrum (PAS; accreta/increta...
We conducted a retrospective study in 82 pregnant women with PAS who underwent ultrasound and MRI examination of the pelvis before delivery (from an initial cohort of 185 women with PAS). We estimated...
Among the 82 patients, 29 (35%) had placenta accreta/increta and 53 (65%) had placenta percreta. The best features to discriminate between placenta accreta/increta and placenta percreta with ultrasoun...
The nomogram we developed to predict the risk of placenta percreta among patients with PAS had good discriminative capabilities. This performance and its impact on maternal morbidity should be confirm...
Although historically pre-eclampsia, preterm birth, abruption, fetal growth restriction and stillbirth have been viewed as clinically distinct entities, a growing body of literature has demonstrated t...
Placental accreta spectrum (PAS) disorder with bladder involvement can be associated with maternal and neonatal morbidity. Magnetic resonance imaging (MRI) may provide accurate preoperative diagnoses....
This study had 2 aims: to retrospectively review the MRI findings for bladder involvement in PAS with placental previa and to correlate bladder involvement with maternal and neonatal outcomes....
MRI images of 48 patients with severe PAS (increta and percreta) with placenta previa/low-lying placenta were evaluated by 2 experienced radiologists blinded to the final diagnoses. Nine MRI findings ...
Of the 48 patients, 27 did not have bladder involvement, while 21 did. Logistic regression analysis identified 2 predictive MRI features for bladder involvement. They were abnormal vascularization (OR...
PAS with bladder involvement was significantly correlated with massive surgical blood loss. Prenatally, the disorder was predicted with high specificity by the combination of loss of chemical shift ar...
To determine the rate of resolution of placenta previa and low-lying placenta (LLP) and the effect of pelvic rest recommendations on the timing of follow-up imaging....
Retrospective review of pregnancies with previa/LLP detected on mid-trimester exam at our ultrasound unit from 2019 to 2021. LLP was defined as the lower edge of placenta located within 2 cm of the in...
Exactly 144 patients had previa and 266 had LLP on the mid-trimester exam with complete records. Previa resolution happened in 51.4% (74/144) of cases. Exactly 62% (46/74) of previa resolutions occurr...
Most societies recommend follow-up imaging at 32 weeks; however, our results suggest this may be done sooner and closer to 28 weeks. Pelvic rest did not affect timing of repeat imaging or delivery....
To determine whether women who experience resolution of low placentation (low-lying placenta or placenta previa) are at increased risk of postpartum hemorrhage compared to those with normal placentati...
This was a retrospective cohort study of women who delivered at Mount Sinai Hospital between 2015 and 2019, and who were diagnosed with low-lying placenta or placenta previa on transvaginal ultrasound...
A total of 1256 women were identified for analysis, of whom 628 had resolved low placentation and 628 had normal placentation. Women with resolved low placentation, compared to those with normal place...
Despite high rates of resolution of low-lying placenta and placenta previa by term, women with resolved low placentation remain at increased risk of postpartum hemorrhage compared to those with normal...